Montalescot G et al. |
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries. |
1990 |
Am. Heart J. |
pmid:2248190
|
Tomoda H |
Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046). |
1986 |
Am. Heart J. |
pmid:3532743
|
Walinsky P et al. |
Thromboxane A2 in acute myocardial infarction. |
1984 |
Am. Heart J. |
pmid:6485997
|
O'Connor KM et al. |
Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion. |
1986 |
Am. Heart J. |
pmid:3953390
|
Austin JC et al. |
Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion. |
1988 |
Am. Heart J. |
pmid:3344655
|
Arora RR et al. |
Laser-induced stimulation of thromboxane B2 synthesis in human blood platelets: role of superoxide radicals. |
1993 |
Am. Heart J. |
pmid:8381256
|
Cambria RA et al. |
Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia. |
1991 |
Am Surg |
pmid:1847027
|
Ingster LM and Feinleib M |
Salicylate intake and cardiovascular disease: Ingster and Feinleib respond to Hu and Willett. |
1998 |
Am J Public Health |
pmid:9702172
|
Satterfield S et al. |
Biochemical markers of compliance in the Physicians' Health Study. |
1990 Sep-Oct |
Am J Prev Med |
pmid:2268456
|
Natarajan G et al. |
Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants. |
2008 |
Am J Perinatol |
pmid:18726836
|
Brown HL et al. |
Plasma and amniotic fluid prostacyclin and thromboxane in mild pregnancy-induced hypertension. |
1987 |
Am J Perinatol |
pmid:3566883
|
Mehta P et al. |
Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. |
1985 |
Am J Pediatr Hematol Oncol |
pmid:2994511
|
Jung TT and Juhn SK |
Prostaglandins in human cholesteatoma and granulation tissue. |
1988 |
Am J Otol |
pmid:3177602
|
Leese PT et al. |
Valdecoxib does not impair platelet function. |
2002 |
Am J Emerg Med |
pmid:12098171
|
Andersson T et al. |
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers. |
2012 |
Am J Cardiovasc Drugs |
pmid:22631032
|
Elissalde MH and Beier RC |
Stimulation and release of prostaglandins and thromboxane from macrophages by cotton dust associated lipopolysaccharides. |
1990 |
Am Ind Hyg Assoc J |
pmid:2270833
|
Tanaka H et al. |
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha. |
1999 |
Allergy |
pmid:10380781
|
Oosaki R et al. |
Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. |
1997 |
Allergy |
pmid:9188934
|
Mita H et al. |
Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. |
2001 |
Allergy |
pmid:11703219
|
Collins CE et al. |
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791957
|
Treiber G et al. |
The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16393293
|
Van Hecken A et al. |
Effects of enteric-coated, low-dose aspirin on parameters of platelet function. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12197849
|
Cole AT et al. |
Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:7865644
|
Carty E et al. |
Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848666
|
Wannhoff A et al. |
Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26919285
|
Signore C et al. |
Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day. |
2008 |
Alcohol. Clin. Exp. Res. |
pmid:18715278
|
Siler-Khodr TM et al. |
Effect of ethanol on thromboxane and prostacyclin production in the human placenta. |
2000 |
Alcohol |
pmid:10963940
|
Hillbom M et al. |
Effects of ethanol on platelet function. |
1985 May-Jun |
Alcohol |
pmid:4026960
|
Shalina RI et al. |
[Synthesis of prostaglandins and lipid peroxidation in pregnant women with gestosis]. |
1988 |
Akush Ginekol (Mosk) |
pmid:3213902
|
Bashakin NF et al. |
[The functional characteristics of the prostacyclin-thromboxane system in newborn infants with a history of acute and chronic intrauterine hypoxia]. |
1993 |
Akush Ginekol (Mosk) |
pmid:8311150
|
Fernández-Cruz E et al. |
Increased synthesis and production of prostaglandin E2 by monocytes from drug addicts with AIDS. |
1989 |
AIDS |
pmid:2496725
|
Patrono C et al. |
Radioimmunoassay measurement of stable metabolites of platelet arachidonic acid: a convenient method for the in vitro and ex vivo evaluation of cyclo-oxygenase inhibitors. |
1980 |
Agents Actions Suppl. |
pmid:6787852
|
Patrono C et al. |
Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment. |
1979 |
Agents Actions Suppl. |
pmid:115255
|
Chignard M et al. |
Arachidonate-mediated bronchoconstriction and platelet activation are inhibited by microgram doses of compound L8027 which are not selective for thromboxane synthetase. |
1979 |
Agents Actions Suppl. |
pmid:291306
|
Peskar BA and Holland A |
Plasma levels of immunoreactive 15-keto-13,14-dihydro-thromboxane B2 in guinea pigs during anaphylaxis and after histamine injection. |
1979 |
Agents Actions Suppl. |
pmid:294148
|
Cerletti C et al. |
Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man. |
1986 |
Agents Actions Suppl. |
pmid:3101444
|
Mihai K et al. |
Association between total cholesterol and thromboxane B2 levels in offspring of parents suffering from premature coronary artery disease. |
1992 |
Agents Actions Suppl. |
pmid:1632293
|
Petö J et al. |
Association between total cholesterol and plasma thromboxane B2 in human adults. |
1992 |
Agents Actions Suppl. |
pmid:1632296
|
Mentz P and Giessler C |
Biosynthesis of TXB2 and 6-oxo-PGF1 alpha in the heart and other tissues under pathophysiological conditions. |
1992 |
Agents Actions Suppl. |
pmid:1632315
|
Ghanem NS et al. |
The cardiac and renal effects of the complement fragment C5a des Arg are partly mediated by the release of histamine and arachidonic acid metabolites. |
1989 |
Agents Actions |
pmid:2473617
|
De Clerck F et al. |
Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the rat. |
1983 |
Agents Actions |
pmid:6858790
|
Nosál R et al. |
Antihistaminic drug bromadryl and stimulated platelet aggregation. |
1994 |
Agents Actions |
pmid:7976789
|
Zatta A et al. |
At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. |
1987 |
Agents Actions |
pmid:2961218
|
de Clerck F et al. |
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist. |
1982 |
Agents Actions |
pmid:6215842
|
de Clerck F et al. |
Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982. |
1994 |
Agents Actions |
pmid:7725978
|
Cifone MG et al. |
Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages. |
1986 |
Agents Actions |
pmid:3825754
|
Carr DP et al. |
Comparison of the systemic inhibition of thromboxane synthesis, anti-inflammatory activity and gastro-intestinal toxicity of non-steroidal anti-inflammatory drugs in the rat. |
1986 |
Agents Actions |
pmid:3825757
|
Berti F et al. |
Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: antagonism by BN-52021. |
1990 |
Agents Actions |
pmid:1696776
|
Nosál R et al. |
Effect of chloroquine on isolated mast cells. |
1991 |
Agents Actions |
pmid:1716835
|
Conti P et al. |
Effect of supernatants from PHA-stimulated and non-stimulated lymphocyte cultures on thromboxane B2 release by polymorphonuclear leukocytes in vitro. |
1985 |
Agents Actions |
pmid:4003201
|